4//SEC Filing
Berman David M 4
Accession 0001955244-25-000011
CIK 0001671927other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:10 PM ET
Size
14.4 KB
Accession
0001955244-25-000011
Insider Transaction Report
Form 4
Berman David M
HEAD OF R&D
Transactions
- Exercise/Conversion
Ordinary Shares
2025-11-24$17.46/sh+100$1,746→ 100 total - Sale
Ordinary Shares
2025-11-24$40.00/sh−100$4,000→ 0 total - Exercise/Conversion
Ordinary Shares
2025-11-25$17.46/sh+18,020$314,629→ 18,020 total - Sale
Ordinary Shares
2025-11-25$40.03/sh−18,020$721,341→ 0 total - Exercise/Conversion
Employee Share Option (Right to Buy)
2025-11-24−100→ 136,690 totalExercise: $17.46Exp: 2028-09-12→ Ordinary Shares (100 underlying) - Exercise/Conversion
Employee Share Option (Right to Buy)
2025-11-25−18,020→ 118,670 totalExercise: $17.46Exp: 2028-09-12→ Ordinary Shares (18,020 underlying)
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Immediately exercisable.
Documents
Issuer
Immunocore Holdings plc
CIK 0001671927
Entity typeother
Related Parties
1- filerCIK 0001955244
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:10 PM ET
- Size
- 14.4 KB